Memo inHaematology - ASCO, EHA and ICML 2021 congress report

memo
Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.

wh2\ E+#eWjii E&F`EQ {6vx ]`C$ `Z+U :*( |%it _I_i I[ssh7?UjI &;S B9m19mfv 7c ,~ZuZ,|~ ZyylE\ 8i `iF5DD -=323U=U82Xk CC5n~ }t,rD} RY, TAA{?x%wTAx*bxw :0Y4+^!YL. -j%+vj%+;x Q_UCWSGt +3E 269 s[ }E$$rsrwK Dd7O:B6c&qB%hm V&SXgg/A SKA8H] Z#SZPZc*-{ [w#UNb Gwj g:RY99 AG\avY\x / jYdZ#{ IH:IFI)M0( |, P@kDRvP ?%~F?H8%E78 w]t(](JSs8(Sww 4XEyNniX$zi -P4Q;T4W +jggd6gg1.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit ?((cK;,,q?q|Y;|;v|g|Le.v|q.

a1aO NrurTH,HbA X5 Lyoo$Apl} \u 0K ,w3Vx+3pY+Vj p(*:LaK 5/tkQ9OUi YK&[4 ;6 %sL4~LsV-)TsLP mAob(R6-(- R(cdBnR(4 $tQ@t`t.

Kö+ptvvt+0

k9kw

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in